Fig. 3.
Probability of survival of 16 adult patients with pro-B ALL treated in GMALL study 03/87 (0.19; median, 571 days) and of 41 adult patients with pro-B ALL treated in GMALL study 04/89 (0.41; median, 747 days). P (log-rank) = .21.
Probability of survival of 16 adult patients with pro-B ALL treated in GMALL study 03/87 (0.19; median, 571 days) and of 41 adult patients with pro-B ALL treated in GMALL study 04/89 (0.41; median, 747 days). P (log-rank) = .21.
